Solaria, a portfolio company of European private equity firm Astorg, has signed definitive agreements to acquire three businesses across natural active ingredients for cosmetics and high-end solutions for diagnostics applications.
The company says that the acquisitions accelerate its international expansion strategy, strengthen its biotechnology platform by broadening its product and innovation capabilities, and reinforce its position as a leading independent player in natural active ingredients. These transactions represent Solabia’s first acquisitions since Astorg’s investment in October 2025.
Headquartered in Paris and founded in 1972, Solabia specialises in natural active ingredients for the cosmetics, nutraceutical, pharmaceutical, food and clinical testing industries.
The company says it leverages biotech capabilities including fermentation, enzymatic synthesis, plant extraction, and green chemistry, to develop ingredients designed to meet formulation requirements and deliver differentiated outcomes for its customer base.
